CoChat

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

Open access
Webb, Julie L., Ravikumar, Brinda, Atkins, Jane, Skepper, Jeremy N., Rubinsztein, David C. · 2003 · Journal of Biological Chemistry

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. alpha-Synuclein is the major protein in Lewy bodies and rare mutations in alpha-synuclein cause early-onset PD. Consequently, alpha-synuclein is implicated in the pathogenesis of PD. Here, we have investigated the degradation pathways of alpha-synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T alpha-synuclein can be switched on and off. We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed alpha-synuclein degradation in these cells. We found that not only is alpha-synuclein degraded by the proteasome, but it is also degraded by autophagy. A role for autophagy was further supported by the presence of alpha-synuclein in organelles with the ultrastructural features of autophagic vesicles. Since rapamycin, a stimulator of autophagy, increased clearance of alpha-synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m300227200

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
FIG. 1 𝛂 -Synuclein is evenly distributed across the cells, often with a vesicular pattern of staining. A , immunofluoresence image of stable, inducible PC12 cells expressing wild-type 𝛂 -synuclein. The cells were differentiated with 100 ng/ml NGF in low serum medium for 5 days and then induced to express wild-type 𝛂 -synuclein with 2 𝛍 g/ml doxycycline. The cells were treated with doxycycline for 10 days before fixing and staining for 𝛂 -synuclein. B , a selection of cells from the same experiment as in A comparing immunofluorescence signals in induced ( I ) and uninduced ( U ) cells. When uninduced cells were imaged by confocal microscopy using the same settings used for the induced cells, no signals were detected. However, staining was detected when the gain settings were increased ( U + ).
FIG. 1 𝛂 -Synuclein is evenly distributed across the cells, often with a vesicular pattern of staining. A , immunofluoresence image of stable, inducible PC12 cells expressing wild-type 𝛂 -synuclein. The cells were differentiated with 100 ng/ml NGF in low serum medium for 5 days and then induced to express wild-type 𝛂 -synuclein with 2 𝛍 g/ml doxycycline. The cells were treated with doxycycline for 10 days before fixing and staining for 𝛂 -synuclein. B , a selection of cells from the same experiment as in A comparing immunofluorescence signals in induced ( I ) and uninduced ( U ) cells. When uninduced cells were imaged by confocal microscopy using the same settings used for the induced cells, no signals were detected. However, staining was detected when the gain settings were increased ( U + ).CC-BY · From the PDF
FIG. 2 Degradation of 𝛂 -synuclein after expression is switched off in the inducible cell lines. Western blot analysis of total exogenous human 𝛂 -synuclein in the inducible PC12 cell lines. Cells were left uninduced ( U ) or induced with 2 𝛍 g/ml doxycycline for 24 h ( I ) or induced for 24 h and then washed to remove doxycycline and left for a further 72 h ( OFF ) in medium. The top panels show the 𝛂 -synuclein band detected with an anti-HA antibody, and the bottom panels show 𝛂 -tubulin as a loading control. Note that where the uninduced and induced lanes appear as separate gel 'strips,' these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from uninduced and induced cells were loaded; intervening lanes were excised to simplify presentation. WT , wild-type.
FIG. 2 Degradation of 𝛂 -synuclein after expression is switched off in the inducible cell lines. Western blot analysis of total exogenous human 𝛂 -synuclein in the inducible PC12 cell lines. Cells were left uninduced ( U ) or induced with 2 𝛍 g/ml doxycycline for 24 h ( I ) or induced for 24 h and then washed to remove doxycycline and left for a further 72 h ( OFF ) in medium. The top panels show the 𝛂 -synuclein band detected with an anti-HA antibody, and the bottom panels show 𝛂 -tubulin as a loading control. Note that where the uninduced and induced lanes appear as separate gel 'strips,' these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from uninduced and induced cells were loaded; intervening lanes were excised to simplify presentation. WT , wild-type.CC-BY · From the PDF
Image 4
CC-BY · From the PDF
FIG. 4 𝛂 -Synuclein is degraded by autophagy. The cells were induced to express 𝛂 -synuclein for 24 h, washed, and then treated with 10 mM 3-MA, 200 nM bafilomycin A1 ( baf ), 0.2 mg/ml rapamycin ( rap ), or controls ( c ) water for 3-MA, Me 2 SO for bafilomycin A1 and rapamycin, for 48 h. Total cell lysate was analyzed for 𝛂 -synuclein content, and loading was checked using 𝛂 -tubulin. A , mitotic cells; B , differentiated cells. Note that where the control and treated lanes appear as separate gel strips, these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from control and treated cells were loaded; intervening lanes were excised to simplify presentation. WT , wild-type.
FIG. 4 𝛂 -Synuclein is degraded by autophagy. The cells were induced to express 𝛂 -synuclein for 24 h, washed, and then treated with 10 mM 3-MA, 200 nM bafilomycin A1 ( baf ), 0.2 mg/ml rapamycin ( rap ), or controls ( c ) water for 3-MA, Me 2 SO for bafilomycin A1 and rapamycin, for 48 h. Total cell lysate was analyzed for 𝛂 -synuclein content, and loading was checked using 𝛂 -tubulin. A , mitotic cells; B , differentiated cells. Note that where the control and treated lanes appear as separate gel strips, these were derived from non-adjacent lanes from the same exposure of blots from single gels where lysates from control and treated cells were loaded; intervening lanes were excised to simplify presentation. WT , wild-type.CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 6 𝛂 -Synuclein is detected inside acidic organelles. Cells were induced for 48 h with 2 𝛍 g/ml doxycycline and then incubated in Earle's balanced salts solution for 2 h at 37 °C to induce starvationmediated autophagy. 75 nM LysoTracker Red was added to the Earle's balanced salts solution medium at the start of the 2 h incubation to label acidic organelles. The cells were then fixed and stained with anti𝛂 -synuclein antibody. Immunostaining was visualized by confocal microscopy. wt , wild-type.
FIG. 6 𝛂 -Synuclein is detected inside acidic organelles. Cells were induced for 48 h with 2 𝛍 g/ml doxycycline and then incubated in Earle's balanced salts solution for 2 h at 37 °C to induce starvationmediated autophagy. 75 nM LysoTracker Red was added to the Earle's balanced salts solution medium at the start of the 2 h incubation to label acidic organelles. The cells were then fixed and stained with anti𝛂 -synuclein antibody. Immunostaining was visualized by confocal microscopy. wt , wild-type.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 2

  1. Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. C. (2000) Biochem. J. 346, 577-581 · DOI · Paper page
  2. Biederbick, A., Kern, H. F., and Elsasser, H. P. (1995) Eur. J. Cell Biol. 66, 3-14

Cited by

Items 501–600 of 1,001

Metadata

Authors
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C.
Affiliations
  • Addenbrooke's Hospital (GB)
  • University of Cambridge (GB)
Corresponding author
Rubinsztein, David C.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-07
Volume
278
Issue
27
Pages
25009-25013
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2157535220
Cited by
1,429
References
37
Citations by year
2026: 36 · 2025: 41 · 2024: 76 · 2023: 50 · 2022: 68 · 2021: 71 · 2020: 83 · 2019: 85 · 2018: 77 · 2017: 62 · 2016: 65 · 2015: 65 · 2014: 75 · 2013: 79 · 2012: 95
FWCI
18.72
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • Parkinson's UK
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
alpha-synuclein, Parkinson's disease, autophagy, proteasome, protein degradation, Lewy bodies, A30P mutation, A53T mutation, PC12 cells, rapamycin, autophagic vesicles, dopaminergic neurons
MeSH terms
Animals, Antibiotics, Antineoplastic, Autophagy, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Nerve Tissue Proteins, PC12 Cells, Sirolimus, Proteasome Endopeptidase Complex, Rats, Synucleins, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.